Clinical Trials in Los Angeles

Showing 14401-14420 of 16,901 trials

RAMP Study: A Study Comparing Two Lumbar Fusion Procedures

NCT01716182

This is a post-marketing, on-label Efficacy, Effectiveness and Safety Study designed in a Multicenter, Randomized, Prospective format. This study compares two spinal fusion procedures, Transacral Interbody Fusion and Transforaminal Lumbar Interbody Fusion (TLIF). Enrollment period will be approximately 12-18 months; each Principal Investigator/Study Center will be expected to enroll up to 20 subjects. The protocol requires approximately 7 subject visits to the study center from screening through the final follow-up visit.

Spinal StenosisSpondylolisthesisDegenerative Disc Disease

Baxano Surgical, Inc.200 participantsStarted Jun 2012

Fullerton, California, United States • Los Angeles, California, United States • Carmel, Indiana, United States +8 more locations

TERMINATEDPhase 3< 1 mile

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases

NCT00654433

Eligible research subjects will receive an unrelated umbilical cord blood transfusion as a possible cure for their inherited metabolic disease. A portion of cord blood cells (ALD-101) will be separated from the cord blood unit and given approximately 4 hours after the standard cord blood transfusion. The study will test if the supplemental cells will increase the speed at which normal levels of circulating blood cells are re-established after transplant.

Inherited Metabolic DiseasesLysosomal Storage DisordersPeroxisomal Storage Diseases+2 more

Aldagen40 participantsStarted Mar 2008

Los Angeles, California, United States • New York, New York, United States • Durham, North Carolina, United States

RAMP Study: A Study Comparing Two Lumbar Fusion Procedures

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases

Find Trials by Condition in Los Angeles

Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

ENDO GIA™ Stapler With ENDO GIA™ Reload With Tri-Staple™ Technology in a Pulmonary Resection

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism

Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes

Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty

Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea